Cytomegalovirus Retinitis Completed Phase 1 Trials for Aldesleukin (DB00041)

Also known as: CMV retinitis / Cytomegaloviral retinitis (disorder) / Cytomegalovirus chorioretinitis / Chorioretinitis caused by Cytomegalovirus (disorder)

IndicationStatusPhase
DBCOND0000283 (Cytomegalovirus Retinitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002321A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) RetinitisTreatment